rhBMP-2 Versus Autograft in Critical Size Tibial Defects
RhBMP-2 vs. Autograft for Critical Size Tibial Defects: A Multicenter Randomized Trial
Sponsor: Major Extremity Trauma Research Consortium
Terminated
Enrollment too slow
Other Tibial Fractures trials with similar outcome
A PHASE4 clinical study on Tibial Fractures, this trial is terminated or withdrawn. The trial is conducted by Major Extremity Trauma Research Consortium and has accumulated 11 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Nov 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jun 2018 — Nov 2018 [monthly]
Terminated PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Terminated PHASE4
-
Dec 2017 — Mar 2018 [monthly]
Terminated PHASE4
-
Oct 2017 — Dec 2017 [monthly]
Terminated PHASE4
-
Feb 2017 — Oct 2017 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Aug 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Major Extremity Trauma Research Consortium
- St. Louis University
For direct contact, visit the study record on ClinicalTrials.gov .